bioRASI, LLC: Clinical Trials

6 trials sponsored by bioRASI, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow bioRASI, LLC: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts
Podofilox Gel 0.5%, Condylox Topical Gel 0.5%, Placebo Gel - External Anogenital Warts
Phase 3CompletedDermax SA4662018-04-202021-07-27
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Permethrin Cream 5% - Scabies
Phase 3CompletedSaptalis Pharmaceuticals LLC1262018-04-102020-10-23
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
Ivermectin 0.5% Topical Application Lotion, Ivermectin 0.5% Topical Application Lotion [SKLICE], Placebo 0% Lotion - Head Lice
Phase 3CompletedMayne Pharma International Pty Ltd2962017-10-022020-09-17
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Varlitinib, Capecitabine, Placebo (for Varlitinib) - Biliary Tract Cancer
Phase 2 / Phase 3CompletedASLAN Pharmaceuticals1512017-07-042021-08-03
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Permethrin Cream, 5%, Elimite - Scabies
Phase 3CompletedMayne Pharma International Pty Ltd1402016-11-012020-09-02
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
Reference: Metronidazole Gel 1%, Test: Metronidazole Gel 1%, Placebo Gel - Papulopustular Rosacea, Erythematotelangiectatic Rosacea
Phase 3CompletedbioRASI, LLC9632015-02-012020-09-03

Conditions studied

Scabies (2)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Neoplasms (1)  ·  Rosacea (1)

Interventions

ARRY-334543 (1)  ·  Capecitabine (1)  ·  Ivermectin (1)  ·  Metronidazole (1)  ·  Permethrin (1)

Countries

United States (6)  ·  Australia (1)  ·  China (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Japan (1)  ·  Poland (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Ukraine (1)

Top investigators

Evgeniy Cherepanov, MD (1)  ·  Phoevos Hughes, JD (1)